Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-652
Closed -$245K 147
2025
Q4
$245K Buy
+652
New +$207K 0.06% 155

Other funds holding AMGN

Opal Capital's AMGN Position: Q1 2026 in Review

Opal Capital sold out of Amgen (AMGN) in Q1 2026, closing a stake of 652 shares — an estimated $245K sold.

Opal Capital first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $245K in Q4 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Opal Capital reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Opal Capital sold 652 Amgen shares in Q1 2026, an estimated $245K.
  • Opal Capital first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
  • Opal Capital's Amgen position peaked at $245K in Q4 2025.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Opal Capital's 13F filing for Q1 2026, filed 18 May 2026.